1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care & Rapid Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Rapid Test
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global Point of Care & Rapid Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Home Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care & Rapid Diagnostics Market Perspective (2018-2029)
2.2 Point of Care & Rapid Diagnostics Growth Trends by Region
2.2.1 Global Point of Care & Rapid Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Point of Care & Rapid Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Point of Care & Rapid Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Point of Care & Rapid Diagnostics Market Dynamics
2.3.1 Point of Care & Rapid Diagnostics Industry Trends
2.3.2 Point of Care & Rapid Diagnostics Market Drivers
2.3.3 Point of Care & Rapid Diagnostics Market Challenges
2.3.4 Point of Care & Rapid Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue
3.1.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Point of Care & Rapid Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Point of Care & Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care & Rapid Diagnostics Revenue
3.4 Global Point of Care & Rapid Diagnostics Market Concentration Ratio
3.4.1 Global Point of Care & Rapid Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care & Rapid Diagnostics Revenue in 2022
3.5 Point of Care & Rapid Diagnostics Key Players Head office and Area Served
3.6 Key Players Point of Care & Rapid Diagnostics Product Solution and Service
3.7 Date of Enter into Point of Care & Rapid Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care & Rapid Diagnostics Breakdown Data by Type
4.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Type (2024-2029)
5 Point of Care & Rapid Diagnostics Breakdown Data by Application
5.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Point of Care & Rapid Diagnostics Market Size (2018-2029)
6.2 North America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
6.4 North America Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care & Rapid Diagnostics Market Size (2018-2029)
7.2 Europe Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
7.4 Europe Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care & Rapid Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Point of Care & Rapid Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care & Rapid Diagnostics Market Size (2018-2029)
9.2 Latin America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care & Rapid Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Detail
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Point of Care & Rapid Diagnostics Introduction
11.1.4 Johnson and Johnson Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.1.5 Johnson and Johnson Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Techne
11.3.1 Bio-Techne Company Detail
11.3.2 Bio-Techne Business Overview
11.3.3 Bio-Techne Point of Care & Rapid Diagnostics Introduction
11.3.4 Bio-Techne Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.3.5 Bio-Techne Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Detail
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Point of Care & Rapid Diagnostics Introduction
11.4.4 Roche Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.4.5 Roche Diagnostics Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Detail
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Point of Care & Rapid Diagnostics Introduction
11.5.4 Siemens Healthineers Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.5.5 Siemens Healthineers Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Point of Care & Rapid Diagnostics Introduction
11.6.4 Abbott Laboratories Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.6.5 Abbott Laboratories Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Detail
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Point of Care & Rapid Diagnostics Introduction
11.7.4 Danaher Corporation Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.7.5 Danaher Corporation Recent Development
11.8 BD
11.8.1 BD Company Detail
11.8.2 BD Business Overview
11.8.3 BD Point of Care & Rapid Diagnostics Introduction
11.8.4 BD Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.8.5 BD Recent Development
11.9 Sysmex
11.9.1 Sysmex Company Detail
11.9.2 Sysmex Business Overview
11.9.3 Sysmex Point of Care & Rapid Diagnostics Introduction
11.9.4 Sysmex Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.9.5 Sysmex Recent Development
11.10 Cardinal Health
11.10.1 Cardinal Health Company Detail
11.10.2 Cardinal Health Business Overview
11.10.3 Cardinal Health Point of Care & Rapid Diagnostics Introduction
11.10.4 Cardinal Health Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.10.5 Cardinal Health Recent Development
11.11 Quidel
11.11.1 Quidel Company Detail
11.11.2 Quidel Business Overview
11.11.3 Quidel Point of Care & Rapid Diagnostics Introduction
11.11.4 Quidel Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.11.5 Quidel Recent Development
11.12 GE Healthcare
11.12.1 GE Healthcare Company Detail
11.12.2 GE Healthcare Business Overview
11.12.3 GE Healthcare Point of Care & Rapid Diagnostics Introduction
11.12.4 GE Healthcare Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.12.5 GE Healthcare Recent Development
11.13 EKF Diagnostics
11.13.1 EKF Diagnostics Company Detail
11.13.2 EKF Diagnostics Business Overview
11.13.3 EKF Diagnostics Point of Care & Rapid Diagnostics Introduction
11.13.4 EKF Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.13.5 EKF Diagnostics Recent Development
11.14 bioMérieux SA
11.14.1 bioMérieux SA Company Detail
11.14.2 bioMérieux SA Business Overview
11.14.3 bioMérieux SA Point of Care & Rapid Diagnostics Introduction
11.14.4 bioMérieux SA Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.14.5 bioMérieux SA Recent Development
11.15 Accubiotech
11.15.1 Accubiotech Company Detail
11.15.2 Accubiotech Business Overview
11.15.3 Accubiotech Point of Care & Rapid Diagnostics Introduction
11.15.4 Accubiotech Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.15.5 Accubiotech Recent Development
11.16 PTS Diagnostics
11.16.1 PTS Diagnostics Company Detail
11.16.2 PTS Diagnostics Business Overview
11.16.3 PTS Diagnostics Point of Care & Rapid Diagnostics Introduction
11.16.4 PTS Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.16.5 PTS Diagnostics Recent Development
11.17 Chembio Diagnostics
11.17.1 Chembio Diagnostics Company Detail
11.17.2 Chembio Diagnostics Business Overview
11.17.3 Chembio Diagnostics Point of Care & Rapid Diagnostics Introduction
11.17.4 Chembio Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.17.5 Chembio Diagnostics Recent Development
11.18 Trinity Biotech
11.18.1 Trinity Biotech Company Detail
11.18.2 Trinity Biotech Business Overview
11.18.3 Trinity Biotech Point of Care & Rapid Diagnostics Introduction
11.18.4 Trinity Biotech Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.18.5 Trinity Biotech Recent Development
11.19 Sekisui Diagnostics
11.19.1 Sekisui Diagnostics Company Detail
11.19.2 Sekisui Diagnostics Business Overview
11.19.3 Sekisui Diagnostics Point of Care & Rapid Diagnostics Introduction
11.19.4 Sekisui Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.19.5 Sekisui Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
